• 華西醫(yī)科大學(xué)附屬第一醫(yī)院普外科(成都610041);

引用本文： 李波. 胰腺癌綜合治療現(xiàn)狀. 中國(guó)普外基礎(chǔ)與臨床雜志, 2000, 7(6): 390-392. doi: 復(fù)制

版權(quán)信息： ?四川大學(xué)華西醫(yī)院華西期刊社《中國(guó)普外基礎(chǔ)與臨床雜志》版權(quán)所有，未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. 李波， 嚴(yán)律南. 晚期胰腺癌的外科姑息性治療 〔Ｊ〕. 腹部外科， 1998； 11(1)∶11.
2. 王志偉， 吳元兵. 胰腺癌診治現(xiàn)狀與進(jìn)展 〔Ｊ〕. 肝膽外科雜志， 1999；11(2)∶111.
3. Mukaiya M, Hirata K, Satoh T, et al. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multiinstiutional analysis in Japan 〔Ｊ〕. World J Surg, 1998; 22(3)∶248.
4. Hawes RH, Xiong Q, Waxman I, et al. A multispeciality approach to the diagnosis and management of pancreatic cancer 〔Ｊ〕. Am J Gastroenterol, 2000; 95(1)∶17.
5. Jakobs R, Riemann JF. The role of endoscopy in acute recurrent and chronic pancreatitis and pancreatic cancer 〔Ｊ〕. Gastroenterol Clin North Am, 1999; 28(3)∶783.
6. Caraceni A, Portenoy RK. Pain management in patients with pancreatic carcinoma 〔Ｊ〕. Cancer, 1996; 78(Suppl 3)∶639.
7. 李華寶， 馬妙發(fā)， 王為民等. 胰腺癌的區(qū)域動(dòng)脈灌注化療 〔Ｊ〕. 中國(guó)局部手術(shù)學(xué)雜志， 1998； 7(3)∶134.
8. 廖泉， 趙玉沛， 蔡力行等. 術(shù)前化療對(duì)胰腺癌細(xì)胞凋亡和組織結(jié)構(gòu)的影響 〔Ｊ〕. 中華外科雜志， 1999； 37(3)∶146.
9. Von Hoff DD, Goodwin AL, Garcia L, et al. Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time 〔Ｊ〕. Br J Cancer, 1998; 78(Suppl 3)∶9.
10. Van der Schelling GP, Jeekel J. Palliative chemotherapy and radiotherapy for pancreatic caner: is it worthwhile 〔Ｊ〕? World J Surg, 1999; 23(9)∶950.
11. Link KH, Formentini A, Leder G, et al. Resection and radiochemotherapy of pancreatic cancerthe future 〔Ｊ〕? Langenbecks Arch Surg, 1998; 383(2)∶134.
12. Michael M, Moore M. Clinical experience with gemcitabin in pancreatic carcinoma 〔Ｊ〕. Oncology Huntingt, 1997; 11(11)∶1615.
13. 韋羽. 用于治療晚期胰腺癌的口服抗癌藥物 〔Ｊ〕. 國(guó)外醫(yī)學(xué)情報(bào)， 1999； 20(6)∶44.
14. 王國(guó)民， 趙森. 胰腺癌的放射治療進(jìn)展 〔Ｊ〕. 腫瘤， 1998； 18(1)∶52.
15. Thomas PR. Radiotherapy for carcinoma of the pancreas 〔Ｊ〕. Semin Oncol, 1996; 23(2)∶213.
16. 王石林， 歐陽(yáng)璽， 劉清珍等. 微波固化治療晚期胰腺癌的研究 〔Ｊ〕. 空軍總醫(yī)院學(xué)報(bào)， 1997； 13(2)∶87.
17. 張世能，袁世珍. 胰腺癌基因治療研究進(jìn)展 〔Ｊ〕. 世界華人消化雜志， 1999； 7(3)∶269.
18. Humphreys MJ, Greenhalf W, Neoptolemos JP, et al. The potential for gene therapy in pancreatic cancer 〔Ｊ〕. Int J Pancreatol, 1999; 26(1)∶5.
19. Staib L, Link KH, Beger HG. Immunotherapy in pancreatic cancercurrent status and future 〔Ｊ〕. Langenbecks Arch Surg, 1999; 384(4)∶396.
20. Andren Sandberg A, Hoem D, Backman PL. Other risk factors for pancreatic cancer: hormonal aspects 〔Ｊ〕. Ann Oncol, 1999; 10(Suppl 4)∶131.
21. Brian A Greenway, 楊尹默. 氟他胺對(duì)胰腺癌患者生存時(shí)間的影響： 隨機(jī)、雙盲、安慰劑對(duì)照的前瞻性研究 〔Ｊ〕. 英國(guó)醫(yī)學(xué)雜志(中文版)， 1999； 2(2)∶72.
  1. 1. 李波， 嚴(yán)律南. 晚期胰腺癌的外科姑息性治療 〔Ｊ〕. 腹部外科， 1998； 11(1)∶11.
  2. 2. 王志偉， 吳元兵. 胰腺癌診治現(xiàn)狀與進(jìn)展 〔Ｊ〕. 肝膽外科雜志， 1999；11(2)∶111.
  3. 3. Mukaiya M, Hirata K, Satoh T, et al. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multiinstiutional analysis in Japan 〔Ｊ〕. World J Surg, 1998; 22(3)∶248.
  4. 4. Hawes RH, Xiong Q, Waxman I, et al. A multispeciality approach to the diagnosis and management of pancreatic cancer 〔Ｊ〕. Am J Gastroenterol, 2000; 95(1)∶17.
  5. 5. Jakobs R, Riemann JF. The role of endoscopy in acute recurrent and chronic pancreatitis and pancreatic cancer 〔Ｊ〕. Gastroenterol Clin North Am, 1999; 28(3)∶783.
  6. 6. Caraceni A, Portenoy RK. Pain management in patients with pancreatic carcinoma 〔Ｊ〕. Cancer, 1996; 78(Suppl 3)∶639.
  7. 7. 李華寶， 馬妙發(fā)， 王為民等. 胰腺癌的區(qū)域動(dòng)脈灌注化療 〔Ｊ〕. 中國(guó)局部手術(shù)學(xué)雜志， 1998； 7(3)∶134.
  8. 8. 廖泉， 趙玉沛， 蔡力行等. 術(shù)前化療對(duì)胰腺癌細(xì)胞凋亡和組織結(jié)構(gòu)的影響 〔Ｊ〕. 中華外科雜志， 1999； 37(3)∶146.
  9. 9. Von Hoff DD, Goodwin AL, Garcia L, et al. Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time 〔Ｊ〕. Br J Cancer, 1998; 78(Suppl 3)∶9.
  10. 10. Van der Schelling GP, Jeekel J. Palliative chemotherapy and radiotherapy for pancreatic caner: is it worthwhile 〔Ｊ〕? World J Surg, 1999; 23(9)∶950.
  11. 11. Link KH, Formentini A, Leder G, et al. Resection and radiochemotherapy of pancreatic cancerthe future 〔Ｊ〕? Langenbecks Arch Surg, 1998; 383(2)∶134.
  12. 12. Michael M, Moore M. Clinical experience with gemcitabin in pancreatic carcinoma 〔Ｊ〕. Oncology Huntingt, 1997; 11(11)∶1615.
  13. 13. 韋羽. 用于治療晚期胰腺癌的口服抗癌藥物 〔Ｊ〕. 國(guó)外醫(yī)學(xué)情報(bào)， 1999； 20(6)∶44.
  14. 14. 王國(guó)民， 趙森. 胰腺癌的放射治療進(jìn)展 〔Ｊ〕. 腫瘤， 1998； 18(1)∶52.
  15. 15. Thomas PR. Radiotherapy for carcinoma of the pancreas 〔Ｊ〕. Semin Oncol, 1996; 23(2)∶213.
  16. 16. 王石林， 歐陽(yáng)璽， 劉清珍等. 微波固化治療晚期胰腺癌的研究 〔Ｊ〕. 空軍總醫(yī)院學(xué)報(bào)， 1997； 13(2)∶87.
  17. 17. 張世能，袁世珍. 胰腺癌基因治療研究進(jìn)展 〔Ｊ〕. 世界華人消化雜志， 1999； 7(3)∶269.
  18. 18. Humphreys MJ, Greenhalf W, Neoptolemos JP, et al. The potential for gene therapy in pancreatic cancer 〔Ｊ〕. Int J Pancreatol, 1999; 26(1)∶5.
  19. 19. Staib L, Link KH, Beger HG. Immunotherapy in pancreatic cancercurrent status and future 〔Ｊ〕. Langenbecks Arch Surg, 1999; 384(4)∶396.
  20. 20. Andren Sandberg A, Hoem D, Backman PL. Other risk factors for pancreatic cancer: hormonal aspects 〔Ｊ〕. Ann Oncol, 1999; 10(Suppl 4)∶131.
  21. 21. Brian A Greenway, 楊尹默. 氟他胺對(duì)胰腺癌患者生存時(shí)間的影響： 隨機(jī)、雙盲、安慰劑對(duì)照的前瞻性研究 〔Ｊ〕. 英國(guó)醫(yī)學(xué)雜志(中文版)， 1999； 2(2)∶72.